Bergan Kdv Wealth Management, LLC Immunity Bio, Inc. Transaction History
Bergan Kdv Wealth Management, LLC
- $999 Million
- Q2 2023
A detailed history of Bergan Kdv Wealth Management, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Bergan Kdv Wealth Management, LLC holds 115 shares of IBRX stock, worth $721. This represents 0.0% of its overall portfolio holdings.
Number of Shares
115
Previous 115
-0.0%
Holding current value
$721
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding IBRX
# of Institutions
191Shares Held
66.7MCall Options Held
2.27MPut Options Held
3.23M-
State Street Corp Boston, MA14.2MShares$88.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.5MShares$84.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.4MShares$65.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.48MShares$21.8 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V81.55MShares$9.71 Million0.01% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $2.51B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...